Three key drivers of the perennial increase in OA prevalence are population growth, aging, and obesity, said authors of the analysis for the Global Burden of Disease study.
Investigators report a 30% reduced risk of total joint replacement in persons with type 2 diabetes treated with metformin vs those who did not receive the drug.
Findings from the University of Michigan National Poll on Healthy Aging highlight the need for clinicians to raise the topic of joint pain with their older patients.